CERo Therapeutics Holdings Overview
Valuation check: CERO's P/E ratio is -0.0, below the sector sector average of 34.88.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, CERO shows a P/E ratio of -0.0. That is below the sector sector average of 34.88. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 34.88. CERo Therapeutics Holdings is at -0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how CERO stacks up against individual peers as well.
Investors watch CERO's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. CERo Therapeutics Holdings's latest reading is -0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has CERo Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -0.0) with ownership activity and broader fundamentals.
